About 115,000 results
Open links in new tab
GSK touts 3-year data on RSV shot Arexvy after CDC's narrower …
GSK says RSV vaccine protects against disease over three seasons
GSK RSV shot 43% effective against severe disease in third year
GSK Presents Positive Data for AREXVY, Its Respiratory ... - BioSpace
GSK presents positive data for AREXVY, its respiratory syncytial …
GSK presents positive data for Arexvy, its respiratory syncytial …
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
US FDA approves GSK’s AREXVY, the world’s first respiratory …
New data for AREXVY, GSK’s RSV vaccine, show potential to help …